Robert Benjamin Stein - 12 Sep 2022 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Role: President, Regenerative Med.
Signature: /s/ William F. Hulse as attorney in fact for Robert Benjamin Stein
Issuer symbol: MDXG
Transactions as of: 12 Sep 2022
Net transactions value: -$94,069
Form type: 4
Filing time: 14 Sep 2022, 20:17:28 UTC
Previous filing: 16 Aug 2022
Next filing: 09 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDXG	Common Stock	Sale	$65,284	-19,000	-6.2%	$3.44	287,002	12 Sep 2022	Direct	F1
transaction	MDXG	Common Stock	Sale	$28,785	-8,329	-2.9%	$3.46	278,673	13 Sep 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.42 to $3.45, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Content

The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.42 to $3.45, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.